Schonfeld Strategic Advisors LLC Neurocrine Biosciences Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 30,413 shares of NBIX stock, worth $3.55 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
30,413
Previous 47,694
36.23%
Holding current value
$3.55 Million
Previous $6.58 Million
36.35%
% of portfolio
0.03%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
95.4MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$538 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$288 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$276 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...